Scientists develop a new tool for imprinting biochips
A new technology could allow researchers to fit more biochemical probes onto a single biochip and reduce the cost of screening and analyzing changes associated with disease development...
List view / Grid view
A new technology could allow researchers to fit more biochemical probes onto a single biochip and reduce the cost of screening and analyzing changes associated with disease development...
The FDA has approved Trogarzo for adult patients whose HIV infections cannot be successfully treated...
Scientists reveal that this dangerous drug could suppress nerve cell death...
Tenofovir disoproxil fumarate (TDF) does not significantly reduce mother-to-child transmission of hepatitis B virus when taken during pregnancy and after delivery.
Researchers report on GS-5734, a promising experimental broad-spectrum antiviral drug...
Researchers have developed a new method to predict the physical stability of drug candidates, which could help with the development of new and more effective medicines for patients...
A naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures...
Scientists have found a way to effectively stop internal bleeding by magnetically-driven nanoparticles containing thrombin...
Broadly neutralising antibody treatment may target viral reservoir in monkeys...
Researchers in the US have found that a common practice among physicians to increase the use of steroids for worsening symptoms of asthma in children may be associated with slowing a child’s rate of growth.
An Italian study demonstrates that copper accumulation in tumours can detect prostate cancer recurrence early in patients with biochemical relapse...
First European filing acceptance of a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor in type-1 diabetes...
Improper use of antibiotics may have an unintended consequence of hampering cancer treatments...
On 28 February 2018, Kolb Distribution AG, wholly owned subsidiary of Kuala Lumpur Kepong Berhad (KLK), acquired Elementis Specialties Netherlands (ESN), located in Delden, the Netherlands...
Ponatinib is effective against SCCOHT, a type of ovarian cancer that mostly strikes young women and girls as young as 14 months...